Publications by authors named "P Morimont"
Article Synopsis
- The COVID-19 pandemic overwhelmed hospitals with patients suffering from respiratory issues, prompting the use of an AI-based tool called CACOVID-CT for analyzing chest CT scans.
- A study with 476 patients at the University Hospital of Liege quantified the severity of COVID-19 using metrics like the percentage of lung area affected and CT severity scores.
- The results showed strong correlations between these measurements and important patient outcomes, such as hospital length of stay and risks for ICU admission and mechanical ventilation, indicating that CACOVID-CT can significantly aid in patient management and reduce radiologist workload.
Article Synopsis
- The study examines the effectiveness of extracorporeal cardiopulmonary resuscitation (ECPR) in patients who experience out-of-hospital cardiac arrests (OHCA), focusing on those treated at smaller ECMO centers in Belgium.
- Out of 75 OHCA patients, 21 received ECPR, resulting in a hospital survival rate of 43%, which aligns with international data.
- Key pre-ECPR factors linked to better survival include transient return of circulation before ECPR and higher initial serum bicarbonate levels, suggesting that specific selection criteria can enhance patient outcomes in ECPR settings.
Article Synopsis
- Mechanical ventilation is crucial for treating acute respiratory distress syndrome (ARDS), and recent studies show that lung protective ventilation (LPV) with lower settings can improve survival rates.
- This study assessed the cost-effectiveness of using extra-corporal CO removal (ECCOR) to enable LPV in France by analyzing patient outcomes, health-state distributions, and incremental cost-effectiveness ratios (ICERs).
- Results indicated that both LPV and Ultra-LPV (more intensive use of ECCOR) significantly improved survival compared to standard mechanical ventilation while remaining cost-effective, with ICERs below €50,000 and less than €25,000 per quality-adjusted life year for Ultra-LPV.
Background: There are limited data on Coronavirus disease 2019 (COVID-19) in solid organ transplant patients, especially in heart transplant recipients, with only a few case reports and case series described so far. Heart transplant recipients may be at particular high risk due to their comorbidities and immunosuppressed state.
Case Presentation: This report describes the clinical course and the challenging management of early COVID-19 infection in two heart transplant recipients who tested positive for the SARS-CoV-2 virus in the perioperative period of the transplant procedure.
In December 2019, in Wuhan, a new human infectious pathology was born, COVID-19, consisting above all in pneumoniae, induced by the coronavirus named SARS-CoV-2 because of the respiratory distress it caused (SARS for severe acute respiratory syndrome, and CoV for Coronavirus). A real health and planetary crisis has appeared, much more substantial than that linked to SARS-CoV-1 in 2002-2004 and to MERS-CoV (Middle East Respiratory Syndrome Coronavirus) in 2012. In addition to respiratory damage that can be dramatic, this pathology is complicated by the frequency of cardiovascular, renal and coagulation diseases.
View Article and Find Full Text PDF